Related Experiment Video
Updated: Jul 25, 2026
06:34
An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
Influenza vaccination in 22 developed countries: an update to 1995
D S Fedson1, Y Hirota, H K Shin
1Pasteur Mérieux MSD, Lyon, France.
Vaccine
|October 23, 1997
Summary
Influenza vaccination rates varied across 22 developed countries through 1995. Reimbursement programs significantly boosted vaccine use, highlighting their importance for public health, despite established effectiveness.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- Influenza vaccination is crucial for preventing illness and reducing healthcare burdens.
- Previous reports tracked influenza vaccine uptake in developed nations.
Purpose of the Study:
- To expand and update influenza vaccine use data through 1995 in 18 developed countries.
- To analyze trends in vaccine uptake and identify factors influencing utilization.
Main Methods:
- Comparative analysis of influenza vaccine doses administered per 1000 population across 22 countries.
- Examination of vaccination reimbursement programs and their correlation with vaccine use.
Main Results:
- High-vaccine-use countries (US) saw increases, while others remained stable or declined.
- Medium-use countries generally increased uptake; low-use countries showed limited improvement, except Finland.
- Vaccine reimbursement programs were strongly associated with higher vaccine use, irrespective of economic development.
Conclusions:
- National reimbursement programs are key drivers of influenza vaccine uptake.
- Significant disparities in vaccine use persist among developed countries.
- Opportunities remain to increase influenza vaccination coverage and realize full public health benefits.
Related Concept Videos
01:51Vaccinations
Overview
01:26Principles of Disease Surveillance
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
01:28Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...